Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging

Svetlana Bezukladova, View ORCID ProfileJouni Tuisku, View ORCID ProfileMarkus Matilainen, Anna Vuorimaa, View ORCID ProfileMarjo Nylund, Sarah Smith, Marcus Sucksdorff, Mehrbod Mohammadian, Virva Saunavaara, Sini Laaksonen, Johanna Rokka, Juha O. Rinne, Eero Rissanen, View ORCID ProfileLaura Airas
doi: https://doi.org/10.1101/2020.01.09.20017012
Svetlana Bezukladova
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jouni Tuisku
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jouni Tuisku
Markus Matilainen
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Markus Matilainen
Anna Vuorimaa
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjo Nylund
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marjo Nylund
Sarah Smith
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Sucksdorff
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehrbod Mohammadian
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virva Saunavaara
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
3Department of Medical Physics, Division of Medical Imaging, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sini Laaksonen
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Rokka
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juha O. Rinne
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eero Rissanen
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Airas
1Turku PET Centre, University of Turku and Turku University Hospital; Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital; Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Airas
  • For correspondence: laura.airas@utu.fi
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To evaluate in vivo the co-occurrence of microglial activation and microstructural white matter damage in multiple sclerosis (MS) brain, and to examine their association with clinical disability.

Methods 18-kDa translocator protein (TSPO) brain PET imaging was performed for evaluation of microglial activation by using the radioligand [11C](R)-PK11195. TSPO-binding was evaluated as the distribution volume ratio (DVR) from dynamic PET images. Diffusion tensor imaging (DTI) and conventional MRI were performed at the same time. Mean fractional anisotropy (FA) and mean (MD), axial (AD) and radial (RD) diffusivities were calculated within the whole normal appearing white matter (NAWM) and segmented NAWM regions appearing normal in conventional MRI. 55 MS patients and 15 healthy controls were examined.

Results Microstructural damage was observed in the NAWM of MS brain. DTI parameters of MS patients were significantly altered in the NAWM, when compared to an age- and sex-matched healthy control group: mean FA was decreased, and MD, AD and RD were increased. These structural abnormalities correlated with increased TSPO binding in the whole NAWM and in the temporal NAWM (p<0.05 for all correlations; p<0.01 for RD in the temporal NAWM). Both compromised WM integrity and increased microglial activation in the NAWM correlated significantly with higher clinical disability measured with expanded disability status scale (EDSS).

Conclusions Widespread structural disruption in the NAWM is linked to neuroinflammation, and both phenomena associate with clinical disability. Multimodal PET and DTI imaging allows in vivo evaluation of widespread MS pathology not visible using conventional MRI.

Supplemental data: Table e-1. Clinical and conventional MRI parameters of healthy controls and multiple sclerosis patients

Table e-2. The effect of number of gradients (64 vs. 33) on DTI-derived measures

Table e-3. Associations of DTI and TSPO-PET measures in the segmented NAWM with disability and disease severity among MS patients (n=55).

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Financial support for this study was provided by the Finnish Academy, the Sigrid Juselius Foundation and The Finnish MS Foundation.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • First author: Svetlana Bezukladova, Turku PET Centre, Turku University Hospital, P.O. Box 52, 20521 Turku, Finland. Neuroimmunology Unit, Division of Neuroscience, Institute of Experimental Neurology, IRCCS San Raffaele Hospital, Via Olgettina 58, 20132, Milan, Italy. Phone: +390226434854; Fax: +390226434855. E-mail: bezukladova.svetlana{at}hsr.it

  • Financial Disclosures: Financial support for this study was provided by the Finnish Academy, the Sigrid Juselius Foundation and The Finnish MS Foundation.

  • Svetlana Bezukladova – Reports no disclosures

  • Jouni Tuisku was supported by the Alfred Kordelin Foundation, Instrumentarium Science Foundation, Orion Research Foundation, Paulo Foundation, Päivikki and Sakari Sohlberg Foundation and Turku University Hospital Foundation.

  • Markus Matilainen - Reports no disclosures

  • Anna Vuorimaa - Reports no disclosures

  • Marjo Nylund - Reports no disclosures

  • Sarah Smith - Reports no disclosures

  • Marcus Sucksdorff has received personal research grants from the Finnish MS Foundation and the Finnish Medical Foundation

  • Mehrbod Mohammadian - Reports no disclosures

  • Virva Saunavaara - Reports no disclosures

  • Sini Laaksonen - Reports no disclosures

  • Johanna Rokka has received personal research grant from Sigrid Juselius Foundation

  • Juha O. Rinne has received research grants from the Academy of Finland, the Sigrid Juselius Foundation, the Finnish National Neurocenter and Governmental Research Grants (VTR)

  • Eero Rissanen has received speaker honoraria from Teva, Biogen, and Roche, a consultational fee for Merck and personal research grants from Turku University Hospital (State Research Funding) and the Finnish MS Foundation.

  • Laura Airas has received research grants from Academy of Finland, the Sigrid Juselius Foundation, the Finnish National Neurocenter and Governmental Research Grants (VTR), institutional research grant support from Genzyme, and honoraria from Biogen, F. Hoffmann-La Roche Ltd, Genzyme and MerckSerono.

  • Statistical Analysis conducted by Dr. Matilainen, PhD, Ms. Bezukladova, MSc and Mr. Tuisku, MSc from Turku PET Centre, Turku University Hospital and University of Turku.

Data Availability

The raw data used in the preparation of this article can be shared in anonymized format by request of a qualified investigator.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 10, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging
Svetlana Bezukladova, Jouni Tuisku, Markus Matilainen, Anna Vuorimaa, Marjo Nylund, Sarah Smith, Marcus Sucksdorff, Mehrbod Mohammadian, Virva Saunavaara, Sini Laaksonen, Johanna Rokka, Juha O. Rinne, Eero Rissanen, Laura Airas
medRxiv 2020.01.09.20017012; doi: https://doi.org/10.1101/2020.01.09.20017012
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging
Svetlana Bezukladova, Jouni Tuisku, Markus Matilainen, Anna Vuorimaa, Marjo Nylund, Sarah Smith, Marcus Sucksdorff, Mehrbod Mohammadian, Virva Saunavaara, Sini Laaksonen, Johanna Rokka, Juha O. Rinne, Eero Rissanen, Laura Airas
medRxiv 2020.01.09.20017012; doi: https://doi.org/10.1101/2020.01.09.20017012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (240)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1419)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (584)
  • Epidemiology (10297)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2629)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1733)
  • Health Policy (789)
  • Health Systems and Quality Improvement (673)
  • Hematology (266)
  • HIV/AIDS (565)
  • Infectious Diseases (except HIV/AIDS) (12093)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (289)
  • Neurology (2461)
  • Nursing (145)
  • Nutrition (377)
  • Obstetrics and Gynecology (492)
  • Occupational and Environmental Health (568)
  • Oncology (1323)
  • Ophthalmology (401)
  • Orthopedics (146)
  • Otolaryngology (237)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (780)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2397)
  • Public and Global Health (5007)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (528)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (245)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)